Peel Hunt Reaffirms "Buy" Rating for Advanced Medical Solutions Group (LON:AMS)

Key Points

• Peel Hunt has reiterated its "buy" rating for Advanced Medical Solutions Group (AMS), with a price target of GBX 246, indicating a potential upside of 16.31% from the current stock price.
• Other analysts, including Deutsche Bank and Berenberg Bank, have also given buy ratings, with target prices of GBX 275 and GBX 300, respectively.
• AMS reported a quarterly EPS of GBX 5.77, with a projected annual EPS of approximately GBX 9.82 for the current year, reflecting a net margin of 8.49%.

Advanced Medical Solutions Group (LON:AMS - Get Free Report)'s stock had its "buy" rating reiterated by stock analysts at Peel Hunt in a research note issued on Wednesday, Marketbeat reports. They presently have a GBX 246 price objective on the stock. Peel Hunt's price objective suggests a potential upside of 14.95% from the company's previous close.

A number of other research analysts have also recently commented on AMS. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and issued a GBX 275 price objective on shares of Advanced Medical Solutions Group in a report on Wednesday, July 16th. Berenberg Bank restated a "buy" rating and set a GBX 300 price target on shares of Advanced Medical Solutions Group in a research note on Wednesday, September 17th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Advanced Medical Solutions Group has an average rating of "Buy" and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Price Performance

LON:AMS traded up GBX 1.50 during trading hours on Wednesday, hitting GBX 214. 508,488 shares of the stock were exchanged, compared to its average volume of 809,201. Advanced Medical Solutions Group has a 52-week low of GBX 168.40 and a 52-week high of GBX 242. The firm's fifty day moving average price is GBX 205.22 and its 200 day moving average price is GBX 203.11. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01. The company has a market cap of £462.52 million, a P/E ratio of 6,584.62, a P/E/G ratio of 5.00 and a beta of 0.74.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last posted its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 EPS for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, equities research analysts anticipate that Advanced Medical Solutions Group will post 9.8159509 EPS for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.